Woman's Hospital, Louisiana   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: East Baton Rouge LA United States (1968)

Organization Overview

First Clinical Trial
2011
NCT01234649
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Woman's Hospital, Louisiana

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes, Gestational (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Fetal Membranes, Premature Rupture (Phase 4)

Glucose Intolerance (Phase 3)

Hyperandrogenism (Phase 4)

Metabolic Syndrome (Phase 3)

Obstetric Labor, Premature (Phase 4)

Overweight (Phase 3)

Polycystic Ovary Syndrome (Phase 4)

Premature Birth (Phase 4)

Rupture (Phase 4)

Rupture, Spontaneous (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 15